AIDS. 2011 Jun 19;25(10):1333-6.

Treatment of acute hepatitis C virus infection in HIV-infected MSM: the effect of treatment duration.

Lambers FA, Brinkman K, Schinkel J, Spijkerman IJ, Molenkamp R, Coutinho RA, Prins M, van der Meer JT; MOSAIC (MSM Observational Study of Acute Infection with hepatitis C) study group.

Collaborators (3)

Reesink H, van Baarle D, Smit C.

Source

Department of Research, Public Health Service of Amsterdam, Cluster of Infectious Diseases, The Netherlands.

Abstract

We evaluated hepatitis C virus (HCV) treatment and the effect of treatment duration (24 versus 48 weeks) on treatment outcome among 50 HIV-infected men who have sex with men with acute HCV infection in Amsterdam. Overall sustained virological response (SVR) rate was 76%. Treatment duration was not significantly associated with SVR (adjusted odds ratio = 2.32; 95% confidence interval 0.39-13.97), suggesting that 24-week treatment may be sufficient for acute HCV infection in HIV-coinfected patients.

PMID:: 21516025; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Research Support, Non-U.S. Gov't

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Treatment of acute hepatitis C in human immunodeficiency virus-infected patients: the HEPAIG study. [Hepatology. 2010]
Treatment of acute hepatitis C in human immunodeficiency virus-infected patients: the HEPAIG study.
Piroth L, Larsen C, Binquet C, Alric L, Auperin I, Chaix ML, Dominguez S, Duval X, Gervais A, Ghosn J, et al. Hepatology. 2010 Dec; 52(6):1915-21. Epub 2010 Nov 9.
Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy. [AIDS. 2006]
Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy.
Serpaggi J, Chaix ML, Batisse D, Dupont C, Vallet-Pichard A, Fontaine H, Viard JP, Piketty C, Rouveix E, Rouzioux C, et al. AIDS. 2006 Jan 9; 20(2):233-40.
Role of individualization of hepatitis C virus (HCV) therapy duration in HIV/HCV-coinfected individuals. [HIV Med. 2006]
Role of individualization of hepatitis C virus (HCV) therapy duration in HIV/HCV-coinfected individuals.
Hopkins S, Lambourne J, Farrell G, McCullagh L, Hennessy M, Clarke S, Mulcahy F, Bergin C. HIV Med. 2006 May; 7(4):248-54.
Review Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients. [AIDS. 2006]
Review Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients.
Dominguez S, Ghosn J, Valantin MA, Schruniger A, Simon A, Bonnard P, Caumes E, Pialoux G, Benhamou Y, Thibault V, et al. AIDS. 2006 May 12; 20(8):1157-61.
Review Acute hepatitis C and HIV coinfection. [Lancet Infect Dis. 2009]
Review Acute hepatitis C and HIV coinfection.
Dionne-Odom J, Osborn MK, Radziewicz H, Grakoui A, Workowski K. Lancet Infect Dis. 2009 Dec; 9(12):775-83.

See reviews... See all...

Recent activity

Clear Turn Off Turn On

Treatment of acute hepatitis C virus infection in HIV-infected MSM: the effect o...
Treatment of acute hepatitis C virus infection in HIV-infected MSM: the effect of treatment duration.
AIDS. 2011 Jun 19 ;25(10):1333-6.

PubMed
Evidence for short-time divergence and long-time conservation of tissue-specific...
Evidence for short-time divergence and long-time conservation of tissue-specific expression after gene duplication.
Brief Bioinform. 2011 Sep ;12(5):442-8. Epub 2011 Apr 22 .

PubMed
Glycated hemoglobin predicts all-cause, cardiovascular, and cancer mortality in ...
Glycated hemoglobin predicts all-cause, cardiovascular, and cancer mortality in people without a history of diabetes undergoing coronary angiography.
Diabetes Care. 2011 Jun ;34(6):1355-61. Epub 2011 Apr 22 .

PubMed
Differential effect of low-dose aspirin for primary prevention of atheroscleroti...
Differential effect of low-dose aspirin for primary prevention of atherosclerotic events in diabetes management: a subanalysis of the JPAD trial.
Diabetes Care. 2011 Jun ;34(6):1277-83. Epub 2011 Apr 22 .

PubMed
Distinctive TLR7 signaling, type I IFN production, and attenuated innate and ada...
Distinctive TLR7 signaling, type I IFN production, and attenuated innate and adaptive immune responses to yellow fever virus in a primate reservoir host.
J Immunol. 2011 Jun 1 ;186(11):6406-16. Epub 2011 Apr 22 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: